Diabetes results from a late change in the autoimmune response of NOD mice.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Autoimmunity

• Publication date

  1997-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/JAUT.1997.0138PMID 9218753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus.

  2009cited by this paper
• Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice

  2004cited by this paper
• Regulation of autoimmune diabetes: Characteristics of non‐islet‐antigen specific therapies

  1996cited by this paper
• Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

  1996cited by this paper
• Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis.

  1996cited by this paper
• Autoimmune diabetes: Caught in the causality trap?

  1995cited by this paper
• Islet-Infiltrating Lymphocytes from Prediabetic NOD Mice Rapidly Transfer Diabetes to NOD-scid/scid mice

  1995cited by this paper
• Expression of the Co-stimulator Molecule B7–1 in Pancreatic β-Cells Accelerates Diabetes in the NOD Mouse

  1995cited by this paper
• Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein

  1995cited by this paper
• The pathogenesis of insulin-dependent diabetes mellitus.

  1994cited by this paper
• Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse

  1994cited by this paper
• Insulin-dependent diabetes mellitus as an autoimmune disease.

  1994cited by this paper
• Course of pancreatic beta cell destruction in prediabetic NOD mice: a histomorphometric evaluation.

  1994cited by this paper
• Altered cytokine activity in adjuvant inhibition of autoimmune diabetes.

  1993cited by this paper
• Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection.

  1992cited by this paper
• The murine autoimmune diabetes model: NOD and related strains.

  1992cited by this paper
• The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice.

  1991cited by this paper
• Paradoxical lessening of autoimmune processes in non‐obese diabetic mice afterinfection with the diabetogenic variant of encephalomyocarditis virus

  1990cited by this paper
• A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.

  1990cited by this paper
• Prevention of diabetes in non-obese diabetic I-Ak transgenic mice

  1990cited by this paper
• Viruses as therapeutic agents. I. Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence

  1990cited by this paper
• Examination of islets in the pancreas biopsy specimens from newly diagnosed Type 1 (insulin-dependent) diabetic patients

  1990cited by this paper
• Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.

  1990cited by this paper
• Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.

  1989cited by this paper
• Radioassay Determination of Insulin Autoantibodies in NOD Mice: Correlation With Increased Risk of Progression to Overt Diabetes

  1989cited by this paper
• Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice.

  1988cited by this paper
• Prevention of type I diabetes in nonobese diabetic mice by virus infection.

  1988cited by this paper
• Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice

  1987cited by this paper
• Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study.

  1987cited by this paper
• Competitive Insulin Autoantibody Assay: Prospective Evaluation of Subjects at High Risk for Development of Type I Diabetes Mellitus

  1987cited by this paper
• The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

  1986cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• Are Insulin Autoantibodies Markers for Insulin-Dependent Diabetes Mellitus?

  1986cited by this paper
• Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.

  1985cited by this paper
• First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion.

  1985cited by this paper
• Immunological aspect of non-obese diabetic mice: immune islet cell-killing mechanism and cell-mediated immunity

  1984cited by this paper
• Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction.

  1984cited by this paper
• Pre-Type I Diabetes: Linear Loss of Beta Cell Response to Intravenous Glucose

  1984cited by this paper
• Deciding who gets what.

  1983cited by this paper
• Insulin antibodies in insulin-dependent diabetics before insulin treatment.

  1983cited by this paper
• Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

  1981cited by this paper
• Breeding of a non-obese, diabetic strain of mice.

  1980cited by this paper
• Successful Allotransplantation of Mouse Pancreatic Islets to Nonimmunosuppressed Recipients

  1980cited by this paper
• Rubella infection and diabetes mellitus.

  1978cited by this paper
• Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

  1974cited by this paper
• Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus

  1965cited by this paper
• The histocompatibility requirements of ovarian grafts in mice.

  1961cited by this paper
• The histocompatibility requirements of ovarian grafts in mice

  1960cited by this paper

• Autoimmunity: Are we asking the right question?

  2022influential citation
• Circulating platelet-neutrophil aggregates characterize the development of type 1 diabetes in humans and NOD mice

  2022cites this paper
• Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes

  2021cites this paper
• Revisiting multiple models of progression of β‐cell loss of function in type 1 diabetes: Significance for prevention and cure

  2016cites this paper
• Pancreatic Islet Basement Membrane Loss and Remodeling after Mouse Islet Isolation and Transplantation: Impact for Allograft Rejection

  2014cites this paper
• Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.

  2014cites this paper
• Circulating miR-375 as a biomarker of β-cell death and diabetes in mice.

  2013cites this paper
• Fine mapping of type 1 diabetes regions Idd9.1 and Idd9.2 reveals genetic complexity

  2013cites this paper
• FQBSBOTVMGBUFBOEIFQBSBOBTF QMBZLFZSPMFTJONPVTF βDFMMTVSWJWBM BOEBVUPJNNVOFEJBCFUFT

  2012cites this paper
• Male and female NOD mice differentially express peroxisome proliferator-activated receptors and pathogenic cytokines.

  2012cites this paper
• Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes.

  2012cites this paper
• Interleukin-21 Is Critically Required in Autoimmune and Allogeneic Responses to Islet Tissue in Murine Models

  2011cites this paper
• Herbal flavonoids inhibit the development of autoimmune diabetes in NOD mice: proposed mechanisms of action in the example of PADMA 28

  2010cites this paper
• The modulatory capacity of interleukin-21 in the pathogenesis of autoimmune disease.

  2008cites this paper
• 70 – Diabetes and related autoimmune diseases

  2008cites this paper
• Chapter 5 The Pathogenesis of Type 1 Diabetes

  2008cites this paper
• Treatment with sodium tungstate delays diabetes onset and lowers hyperglycemia in the NOD mouse

  2007cites this paper
• Encapsulation of Porcine Islets Permits Extended Culture Time and Insulin Independence in Spontaneously Diabetic BB Rats

  2007cites this paper
• T cells to a dominant epitope of GAD65 express a public CDR3 motif.

  2006cites this paper
• APOPTOSIS DE LAS CÉLULAS BETA DEL PÁNCREAS DURANTE LA DIABETES DE TIPO 1

  2006cites this paper
• Transient Chemokine Receptor Blockade does not Prevent, but may Accelerate Type 1 Diabetes in Prediabetic NOD Mice

  2006cites this paper
• CXCL10 DNA Vaccination Prevents Spontaneous Diabetes through Enhanced β Cell Proliferation in NOD Mice1

  2005cites this paper
• Cell Proliferation in NOD Mice b Spontaneous Diabetes through Enhanced CXCL10 DNA Vaccination Prevents

  2005cites this paper
• The Expression of Cytokine Genes in the Peritoneal Macrophages and Splenic CD4- and CD8-Positive Lymphocytes of the Nonobese Diabetic Mice

  2004cites this paper
• The natural history of insulin content in the pancreas of female and male non‐obese diabetic mouse: implications for trials of diabetes prevention in humans

  2004cites this paper
• Disease prevention with islet autoantigens.

  2004cites this paper
• The pathogenesis of diabetes in the NOD mouse.

  2004cites this paper
• Induction of insulin autoantibodies / insulitis / diabetes in BALB / c mice

  2004cites this paper
• Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154.

  2003cites this paper
• Beta cell MHC class I is a late requirement for diabetes

  2003cites this paper
• Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

  2003cites this paper
• Mechanisms of Accelerated Immune-Mediated Diabetes Resulting from Islet β Cell Expression of a Fas Ligand Transgene1

  2003cites this paper
• Assessment of β Cell Mass and Oxidative Peritoneal Exudate Cells in Murine Type 1 Diabetes using Adoptive Transfer System

  2003influential citation
• Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody1

  2003cites this paper
• Diabetes Therapeutics News

  2002cites this paper
• Reduced Expression of Th 1-Associated Chemokine Receptors on Peripheral Blood Lymphocytes at Diagnosis of Type 1 Diabetes

  2002cites this paper
• beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetic patients: autoaggressive effector T cells damage human CD56(+) beta cells by HLA-restricted and non-HLA-restricted pathways.

  2002cites this paper
• Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.

  2002cites this paper
• Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes.

  2002cites this paper
• How beta cells die in type 1 diabetes.

  2001cites this paper
• Transgenic rescue implicates β2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice

  2001cites this paper
• Reversal of established autoimmune diabetes by restoration of endogenous β cell function

  2001cites this paper
• Is lack of peripheral tolerance induction a cause for diabetes in the non-obese diabetic mouse?

  2000cites this paper
• Isotypes of anti-islet autoantibodies.

  2000cites this paper
• Regulation of TCR-induced IFN-gamma release from islet-reactive non-obese diabetic CD8(+) T cells by prostaglandin E(2) receptor signaling.

  2000cites this paper
• Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.

  2000cites this paper
• Beta cell destruction in the development of autoimmune diabetes in the non‐obese diabetic (NOD) mouse

  2000cites this paper
• Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.

  1999cites this paper
• The role of CD4 and CD8 T cells in the development of autoimmune diabetes.

  1999cites this paper
• Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.

  1999cites this paper
• Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.

  1999cites this paper
• Localising quantitative trait loci in the NOD mouse model of type 1 diabetes.

  1999cites this paper
• A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.

  1999cites this paper
• The role of CD4 vs. CD8 T cells in IDDM.

  1999cites this paper
• Retaining Antiviral Immune Competence Protects from Autoimmune Diabetes While Disruption of the STAT4 Signaling Pathway

  1999cites this paper
• Evidence That b Cell Death in the Nonobese Diabetic Mouse Is Fas Independent 1

  1999cites this paper
• Evidence That β Cell Death in the Nonobese Diabetic Mouse Is Fas Independent

  1999cites this paper
• Autoimmune diabetes: the involvement of benign and malignant autoimmunity.

  1999cites this paper
• Involvement of Fas/FasL system in the pathogenesis of autoimmune diseases and Wilson's disease.

  1999cites this paper
• Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes

  1998cites this paper
• Email: editors, doctors and patients

  1998cites this paper
• Cancer immunotherapy: new leads on an elusive goal

  1998cites this paper
• Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus.

  1998cites this paper
• Antibodies to ICA512/IA-2 in rodent models of IDDM.

  1998cites this paper
• Autoimmune diabetes: how many steps for one disease?

  1997cites this paper
• Tolerance: a case of self/not-self discrimination maintained by clonal deletion?

  1997cites this paper
• CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse.

  1997cites this paper
• Organ-specific autoimmunity.

  1997cites this paper
• The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

  1997cites this paper
• Immunobiology of autoimmune diabetes.

  1997cites this paper